Automated Characterization of Biotherapeutics via Hardware, Software and Chemistry

In this episode, we welcome Dr Harsha Gunawardena, principal scientist at Jansen Research and Development, Johnson & Johnson. 

Harsha discusses bi & multispecific antibodies including the challenges that manufacturers face when developing novel therapeutics. He reveals how scientists at Janssen are working to deliver better analytical methods and advanced data processing tools to help them streamline biotherapeutic development workflows.

Further Reading:

• Protein Metric’s Bispecific Resources
  
• Protein Metric’s Automation Resources
• Webinar – System Suitability Monitoring with Dashboards
• Upcoming Webinar – Antibody Aggregates with Dr Harsha Gunawardena
• Peer Reviewed Paper -  Fully Automated High Throughput Mass Spectrometry for Biotherapeutics